Latest News
Cure SMA and Isis Announce Holiday Card Contest TEST
It’s only September, but the holidays are right around the corner! Cure SMA and Isis Pharmaceuticals are teaming up for a holiday card contest. This contest is open to children […]
Read More ›Cure SMA and Isis Announce Holiday Card Contest
It’s only September, but the holidays are right around the corner! Cure SMA and Isis Pharmaceuticals are teaming up for a holiday card contest. This contest is open to children […]
Read More ›Spinal Muscular Atrophy Biomarker Study Reaches Enrollment Goals
We’re excited to announce that enrollment for the NeuroNEXT biomarker study is now fully filled. This means that this critical study can continue to progress and teach us more about […]
Read More ›Urge Your Senators to Support Passage of the Newborn Screening Saves Lives Reauthorization Act
The Newborn Screening Saves Lives Reauthorization Act (H.R. 1281) passed the House of Representatives this summer but still has not yet received a vote in the Senate. Cure SMA encourages […]
Read More ›Applications for the Cure SMA Medical Advisory Board Due 10/1/14
Cure SMA is expanding its role in spinal muscular atrophy medical affairs at the national level through its Medical Advisory Council (MAC). The MAC sets the agenda for proactive, creative, […]
Read More ›RFP Closes for Spinal Muscular Atrophy Basic Research Funding
On September 5, we announced the close of our for request for proposals (RFP) for basic research. An RFP is an invitation for scientists to submit their best ideas for SMA […]
Read More ›